Good evening :)
$
₹
Elevai Labs, Inc. Common Stock

Elevai Labs, Inc. Common Stock

ELAB

NASDAQ
Asset Logo

Elevai Labs, Inc. Common Stock

ELAB

NASDAQ
$1.71—% (+1.71)
$
₹
$1.71—% (+1.71)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Unknown

Sector and industry information not available

Micro Cap

With a market cap of $1.4M the stock is ranked 5955

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

0.00
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.40
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$151.07
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Peers

Peers

Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
51.53
51.53
1Y Return
23.59%
23.59%
Buy Reco %
66.66
66.66
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
23.97
23.97
1Y Return
34.98%
34.98%
Buy Reco %
67.85
67.85
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
35.46
35.46
1Y Return
3.77%
3.77%
Buy Reco %
88.46
88.46
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
35.35
35.35
1Y Return
21.02%
21.02%
Buy Reco %
68.75
68.75
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
20.61
20.61
1Y Return
9.00%
9.00%
Buy Reco %
53.12
53.12

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Elevai Labs, Inc. Common Stock 0.000.40-
Intuitive Surgical Inc51.538.602.22
Abbott Laboratories23.972.861.27

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here
Loading...